Daxor corporation announces partial exercise of over-allotment option in secondary offering

Oak ridge, tn, june 22, 2023 (globe newswire) -- daxor corporation (nasdaq: dxr), the global leader in blood volume measurement technology, today announced that maxim group llc (“maxim”), as representative of several underwriters of its previously announced secondary public offering have partially exercised their option to purchase an additional 54,339 option shares of daxor's class a common stock (the “over-allotment option”) at a public price of $9.75 per share.
DXR Ratings Summary
DXR Quant Ranking